Chris Daniel

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (6)

• Development of Carprofen analogues with activity against Mycobacterium tuberculosis
  Bioorganic & Medicinal Chemistry 2025 DOI: 10.1016/j.bmc.2025.118226
  +Save
• Modified HT-SPOTi: An Antimicrobial Susceptibility Testing to Evaluate Formulated Therapeutic Combinations Against Bacterial Growth and Viability
  Methods in Molecular Biology 2024 DOI: 10.1007/978-1-0716-3981-8_4
  +Save
• Rapid Gene Silencing Followed by Antimicrobial Susceptibility Testing for Target Validation in Antibiotic Discovery
  Methods in Molecular Biology 2024 DOI: 10.1007/978-1-0716-3981-8_3
  +Save
• Mycobactin analogue interacting with siderophore efflux-pump protein: insights from molecular dynamics simulations and whole-cell assays
  Frontiers in Antibiotics 2024 DOI: 10.3389/frabi.2024.1362516
  +Save
• Rationally Designed Novel Phenyloxazoline Synthase Inhibitors: Chemical Synthesis and Biological Evaluation to Accelerate the Discovery of New Antimycobacterial Antibiotics
  Mousumi Shyam, Gourab Bhattacharje, Chris Daniel +9 more
  Molecules 2023 DOI: 10.3390/molecules28248115
  +Save
• Immunobiology of tubercle bacilli and prospects of immunomodulatory drugs to tackle tuberculosis (TB) and other non-tubercular mycobacterial infections
  Immunobiology 2022 DOI: 10.1016/j.imbio.2022.152224
  +Save